INTRODUCTION
GCH1 has been implicated in Parkinson's disease (PD), but its risks variants and associations are not well defined.
OBJECTIVES
Our goal was to investigate the clinical relevance and PD risk associated with the GCH1 p.Ser80Asn variant.
METHODS
We first identified a segregating GCH1 p.Ser80Asn variant in...
Yi-Wen Tay, A. Lee, J. Schee et al.· Movement Disorders· 0 citations
Timely identification of Parkinson’s disease (PD) is often delayed because of clinical heterogeneity and limited awareness of early symptoms. Digital biomarkers obtained via smartphones offer scalable screening potential. However, unimodal assessments may lack sufficient sensitivity or specificity given the multidimens...
Kyungsung Lee, Han-Joon Kim, J. Shin et al.· Neurological Therapeutics· 0 citations
Patient-Aware Contextual and Evidence-Constrained RAG personalizes recommendations by first extracting patient-specific clinical features, retrieving cases around these features, and then refining the final prescription using the patient's current symptoms, active medication history, and focus-specific prescribing tend...
C. Huh, Hyunmin Hwang, J. Shin et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.